NovoCure (NVCR) Non-Current Deffered Revenue (2014 - 2023)
NovoCure (NVCR) posted Non-Current Deffered Revenue of $807000.0 for Q2 2023, down 56.21% sequentially from $1.8 million in Q1 2023, and down 82.23% YoY from $4.5 million in Q2 2022.
NovoCure (NVCR) Non-Current Deffered Revenue (2014 - 2023) Analysis & Trends
NovoCure has reported Non-Current Deffered Revenue for 10 years, with the latest figure at $807000.0 in Q2 2023.
- Quarterly Non-Current Deffered Revenue fell 82.23% year-over-year to $807000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $807000.0 (down 82.23% YoY) and the FY2022 annual result came in at $2.9 million, down 55.57% from the prior year.
- Non-Current Deffered Revenue retreated to $807000.0 in Q2 2023 per NVCR's latest filing, from $1.8 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $12.1 million in Q4 2020 and troughed at $807000.0 in Q2 2023.
- A 5-year average of $7.0 million and a median of $7.9 million in 2019 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2020 and 2023: Non-Current Deffered Revenue soared 55.49% in 2020, then sank 82.23% in 2023.
- Over 5 years, Non-Current Deffered Revenue stood at $7.8 million in 2019, then jumped by 55.49% to $12.1 million in 2020, then plunged by 46.64% to $6.5 million in 2021, then slumped by 55.57% to $2.9 million in 2022, then slumped by 71.96% to $807000.0 in 2023.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $807000.0, $1.8 million, and $2.9 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 807,000.00 |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.88 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 4.54 Mn |
| Mar 31, 2022 | 5.51 Mn |
| Dec 31, 2021 | 6.48 Mn |
| Sep 30, 2021 | 7.46 Mn |
| Jun 30, 2021 | 8.35 Mn |
| Mar 31, 2021 | 9.58 Mn |
| Dec 31, 2020 | 12.14 Mn |
| Sep 30, 2020 | 10.86 Mn |
| Jun 30, 2020 | 8.02 Mn |
| Mar 31, 2020 | 8.77 Mn |
| Dec 31, 2019 | 7.81 Mn |
| Sep 30, 2019 | 8.34 Mn |
| Jun 30, 2019 | 8.87 Mn |
| Mar 31, 2019 | 9.41 Mn |
| Dec 31, 2018 | 9.93 Mn |
| Dec 31, 2017 | 746,000.00 |